A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.
Evotec SE provides guidance update – Biotech Investments
Evotec SE / Key word(s): Change in Forecast Evotec SE provides guidance update 06-Aug-2024 / 21:04 CET/CEST Disclosure of an inside information acc. to Article